Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer

被引：0
|
作者：
Muneaki Shimada
Shinya Sato
Tetsuro Oishi
Hiroaki Itamochi
Junzo Kigawa
Nobuhiro Takeshima
Daisuke Aoki
Yoichi Aoki
Yoshihiro Nambu
Kazunori Ochiai
机构：
[1] Tottori University School of Medicine,Department of Obstetrics and Gynecology
[2] Iwate Medical University,Department of Obstetrics and Gynecology
[3] Matsue City Hospital,Department of Gynecology
[4] Cancer Institute Hospital,Department of Obstetrics and Gynecology
[5] Keio University School of Medicine,Department of Obstetrics and Gynecology, Graduate School of Medical Science
[6] University of the Ryukyus,Pharmaceuticals Group
[7] Nippon Kayaku Co.,Department of Obstetrics and Gynecology
[8] Ltd.,undefined
[9] Jikei University School of Medicine,undefined
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Uterine cervical cancer; Chemotherapy; Nogitecan hydrochloride (topotecan); Cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：969 / 974
页数：5
相关论文
共 50 条
  • [1] Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer
    Shimada, Muneaki
    Sato, Shinya
    Oishi, Tetsuro
    Itamochi, Hiroaki
    Kigawa, Junzo
    Takeshima, Nobuhiro
    Aoki, Daisuke
    Aoki, Yoichi
    Nambu, Yoshihiro
    Ochiai, Kazunori
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (05) : 969 - 974
  • [2] Topotecan with in combination cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer
    Brave, Michael
    Dagher, Ramzi
    Farrell, Ann
    Abraham, Sophia
    Ramchandani, Roshni
    Gobburu, Jogarao
    Booth, Brian
    Jiang, Xiaoping
    Sridhara, Rajeshwari
    Justice, Robert
    Pazdur, Richard
    [J]. ONCOLOGY-NEW YORK, 2006, 20 (11): : 1401 - +
  • [3] Bevacizumab plus chemotherapy versus combination chemotherapy only in metastatic, recurrent, and persistent cervical cancer
    Choi, H.
    Kim, B. G.
    Lee, Y. Y.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 275 - 275
  • [4] Phase II trial of topotecan, cisplatin, and bevacizurnab for recurrent or persistent cervical cancer
    Zighelboim, I.
    Wright, J. D.
    Powell, M. A.
    Case, A. S.
    Eisenhauer, E. L.
    Cohn, D. E.
    Valea, F. A.
    Secord, A. A.
    Lippmann, L. T.
    Rader, J. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer
    Zighelboim, Israel
    Wright, Jason D.
    Gao, Feng
    Case, Ashley Stephens
    Massad, L. Stewart
    Mutch, David Gardner
    Powell, Matthew A.
    Thaker, Premal H.
    Eisenhauer, Eric Lawernce
    Cohn, David E.
    Valea, Fidel A.
    Secord, Angeles Alvarez
    Lippmann, Lynne T.
    Rader, Janet Sue
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer
    Eskander, Ramez N.
    Tewari, Krishnansu S.
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (04) : 314 - 321
  • [7] The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer
    Moon, Ji Young
    Song, Ik-Chan
    Ko, Young Bok
    Lee, Hyo Jin
    [J]. MEDICINE, 2018, 97 (14)
  • [8] A phase II study of atezolizumab in combination with bevacizumab in patients with recurrent, persistent or metastatic cervical cancer
    Friedman, C. F.
    Snyder, A.
    Sharon, E.
    De Meritens, A. Buckley
    Cantrell, L. A.
    Corr, B. R.
    Konner, J.
    Konstantinopoulos, P. A.
    Soldan, K.
    Aghajanian, C. A.
    Zamarin, D.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 17 - 18
  • [9] Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
    Zighelboim, Israel
    Wright, Jason D.
    Gao, Feng
    Case, Ashley S.
    Massad, L. Stewart
    Mutch, David G.
    Powell, Matthew A.
    Thaker, Premal H.
    Eisenhauer, Eric L.
    Cohn, David E.
    Valea, Fidel A.
    Secord, Angeles Alvarez
    Lippmann, Lynne T.
    Dehdashti, Farrokh
    Rader, Janet S.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 64 - 68
  • [10] COMPARING OUTCOMES OF COMBINATION CHEMOTHERAPY BETWEEN PACLITAXEL/IFOSFAMIDE/CISPLATIN AND PACLITAXEL/CISPLATIN FOR THE PATIENTS WITH RECURRENT OR PERSISTENT CERVICAL CANCER: RETROSPECTIVE ANALYSIS
    Choi, H. J.
    Kim, J. H.
    Park, J. Y.
    Lee, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 724 - 724
12345